Lifeboat Foundation

Circa 2017

Someday, it could carry supplies to soldiers on the battlefield.

The discovery is the first step in developing a stem cell therapy to help patients recover from bone fractures, spinal fusion, and osteoporosis.

• Russia is said to have built a new 100-megaton underwater nuclear doomsday device, and it has threatened the US with it.
• The device goes beyond traditional ideas of nuclear warfighting and poses a direct threat to the future of humanity or life on Earth.
• Nobody has ever built a weapon like this before, because there’s almost no military utility in so badly destroying the world.
• But an expert on nuclear strategy told Business Insider the weapon might have a larger role in helping Russian President Vladimir Putin break down NATO with the threat of nuclear destruction.

Since 2015, when images of a Russian nuclear torpedo first leaked on state television, the world has asked itself why Moscow would build a weapon that could end all life on Earth.

While all nuclear weapons can kill thousands in the blink of an eye and leave radiation poisoning the environment for years to come, Russia’s new doomsday device, called “Poseidon,” takes steps to maximize this effect.

Forty-one percent of the world’s insects are in decline as part of the sixth mass extinction. If the decline continues, Earth could be devoid of insects in 100 years.

Combining human and artificial intelligence in autonomous vehicles could push driverless cars more quickly toward wide-scale adoption, University of Michigan researchers say.

That’s the goal of a new project that relies on a technique called instantaneous crowdsourcing to provide a cost-effective, real-time remote backup for onboard autonomous systems without the need for a human to be physically in the driver’s seat. The research is taking place at the U-M Transportation Research Institute (UMTRI).

The need for human safety drivers in vehicles like Waymo’s recently introduced autonomous taxis undermines their cost advantage compared to traditional ride sharing services, the researchers say. It also keeps the era of cars as autonomous rolling living rooms tantalizingly out of reach. And most researchers agree that machines won’t be able to completely take over driving duties for years or even decades.

Continue reading “‘Air traffic control’ for driverless cars could speed up deployment” »

The history of the universe is predicated on the idea that, compared to today, the universe was hotter and more symmetric in its early phase. Scientists have thought this because of the Higgs Boson finding—the particle that gives mass to all other fundamental particles. The concept is that as one analyzes time back toward the Big Bang, the universe gets hotter and the Higgs phase changes to one where everything became massless. Now, physicists are presenting a new theory that suggests an alternative history of the universe is possible.

By discovering the culprit behind decreased blood flow in the brain of people with Alzheimer’s, biomedical engineers at Cornell University have made possible promising new therapies for the disease.

You know that dizzy feeling you get when, after lying down for an extended period, you stand up a little too quickly?

That feeling is caused by a sudden reduction of blood flow to the brain, a reduction of around 30 percent. Now imagine living every minute of every day with that level of decreased blood flow.

Continue reading “Researchers closer to new Alzheimer’s therapy with brain blood flow discovery” »

We recently visited the Longevity Leaders Conference in London and had the opportunity to speak with Kelsey Moody, the CEO of Ichor Therapeutics, a company focused on targeting age-related diseases by targeting the aging processes themselves. We previously interviewed him back in 2017, so it was the ideal time to catch up on what had been happening with his company since then.

Ichor and its portfolio companies have been very busy over the last year, so I thought it was time that we caught up on progress. Can you tell us how things are going for the Ichor group?

Ichor really had a good year in 2018. We raised over $16 million across our portfolio, and that’s really allowed us to scale up all aspects of our operations. We’re at over 50 employees now, mostly bench scientists and research technicians, and we’re really delivering on our goal of being a vertically integrated biopharmaceutical company.

Continue reading “An Interview with Kelsey Moody – Developing a Company to End Age-Related Diseases” »

“We found that lactate stimulates synaptic activity-dependent genes in the short-term and genes involved in regulating neuronal excitability in the long-term,” explains the first author of the paper Michael Margineanu, a KAUST Master’s student.

Study illustrates the links between brain energy metabolism and neuronal activity.

A genome-wide study led by Dean Pierre Magistretti sheds light on the mechanisms through which lactate regulates long-term memory formation and neuroprotection.

Continue reading “Lactate activates multiple genes that modulate neuronal activity” »